{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:06:01Z","timestamp":1777521961262,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007579","name":"Auburn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.sapharm.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T20:57:24Z","timestamp":1419022644000},"page":"708-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments"],"prefix":"10.1016","volume":"11","author":[{"given":"Saranrat","family":"Wittayanukorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salisa C.","family":"Westrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedret","family":"Billor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2001.19.5.1455","article-title":"Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data","volume":"19","author":"Du","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jnci\/94.7.490","article-title":"Race, socioeconomic status, and breast cancer treatment and survival","volume":"94","author":"Bradley","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sapharm.2014.12.002_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.2013.8272","article-title":"Characteristics associated with differences in survival among black and white women with breast cancer","volume":"310","author":"Silber","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2014.12.002_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jama.281.8.720","article-title":"Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison","volume":"281","author":"Riley","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2006.10.2749","article-title":"Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens","volume":"25","author":"Griggs","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib6","first-page":"922","article-title":"Vital signs: racial disparities in breast cancer severity\u2013United States, 2005\u20132009","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2014.12.002_bib7","first-page":"78","article-title":"Cancer disparities by race\/ethnicity and socioeconomic status","volume":"54","author":"Ward","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.sapharm.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment","volume":"97","author":"Edwards","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sapharm.2014.12.002_bib9","series-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"Howlader","year":"2013"},{"key":"10.1016\/j.sapharm.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","article-title":"Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research","volume":"18","author":"Wheeler","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.sapharm.2014.12.002_bib11","first-page":"1","article-title":"National hospital ambulatory medical care survey: 2006 emergency department summary","author":"Pitts","year":"2008","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.sapharm.2014.12.002_bib12","series-title":"Cancer Facts & Figures","year":"2014"},{"issue":"1","key":"10.1016\/j.sapharm.2014.12.002_bib13","first-page":"52","article-title":"Breast cancer statistics, 2013","volume":"64","author":"Desantis","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.sapharm.2014.12.002_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","article-title":"Racial and ethnic disparities in the receipt of cancer treatment","volume":"94","author":"Shavers","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sapharm.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/MLR.0b013e31819e1fe7","article-title":"Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?","volume":"47","author":"Keating","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1075-122X.2004.21357.x","article-title":"Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997","volume":"10","author":"Du","year":"2004","journal-title":"Breast J"},{"key":"10.1016\/j.sapharm.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2407-9-364","article-title":"Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.sapharm.2014.12.002_bib18","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from\u00a0breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2014.12.002_bib19","unstructured":"Multum Lexicon Database. Cerner Multum, Inc. http:\/\/www.multum.com\/Lexicon.html; Accessed 13.04.14."},{"key":"10.1016\/j.sapharm.2014.12.002_bib20","unstructured":"Ambulatory Health Care Data. http:\/\/www.cdc.gov\/nchs\/ahcd\/about_ahcd.htm; Accessed 13.04.14."},{"key":"10.1016\/j.sapharm.2014.12.002_bib21","series-title":"NCCN Clinican Practice Guideline in Oncology (NCCN Guideline) Version 3.2104","year":"2014"},{"key":"10.1016\/j.sapharm.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2011.36.8399","article-title":"Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers","volume":"30","author":"Wu","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib23","series-title":"Reliability of Estimates","year":"2010"},{"key":"10.1016\/j.sapharm.2014.12.002_bib24","series-title":"SEER Summary Staging Manual-2000: Codes and Coding Instructions","author":"Young","year":"2001"},{"key":"10.1016\/j.sapharm.2014.12.002_bib25","first-page":"1350","article-title":"Ambulatory care for cancer in the United States: results from two national surveys comparing visits to physicians' offices and hospital outpatient departments","volume":"99","author":"Richardson","year":"2007","journal-title":"J Natl Med Assoc"},{"issue":"suppl 6","key":"10.1016\/j.sapharm.2014.12.002_bib26","doi-asserted-by":"crossref","first-page":"vi12","DOI":"10.1093\/annonc\/mdr371","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Aebi","year":"2011","journal-title":"Ann Oncol"},{"issue":"suppl 7","key":"10.1016\/j.sapharm.2014.12.002_bib27","doi-asserted-by":"crossref","first-page":"vii11","DOI":"10.1093\/annonc\/mds232","article-title":"Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Cardoso","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1200\/JCO.2005.04.5799","article-title":"Missed opportunities: racial disparities in adjuvant breast cancer treatment","volume":"24","author":"Bickell","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib29","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2012.41.9564","article-title":"Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample","volume":"30","author":"Griggs","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1532-5415.2004.52018.x","article-title":"Effect of depression on diagnosis, treatment, and survival of older women with breast cancer","volume":"52","author":"Goodwin","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"30","author":"Griggs","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sapharm.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2215-0366(14)70313-X","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data","volume":"1","author":"Walker","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.sapharm.2014.12.002_bib33","series-title":"Understanding and Using NAMCS and NHAMCS Data. Data Tools and Basic Programming Techniques","year":"2010"},{"key":"10.1016\/j.sapharm.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/cer.12.43","article-title":"Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey","volume":"1","author":"DeKoven","year":"2012","journal-title":"J Comp Eff Res"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741114004082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741114004082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:10:28Z","timestamp":1761556228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741114004082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1551741114004082"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2014.12.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}